賽諾醫療(688108.SH)：多名董監高減持實施完成
格隆匯7月17日丨賽諾醫療(688108.SH)公佈，截至2025年7月16日，公司董事、副總經理、核心技術人員康小然先生累計減持公司股份168,000股，佔減持前公司股份總數的0.0406%，本次減持計劃已部分實施完畢。本次減持後，其合計持有公司股份數量1,588,399股，佔減持後公司股份總數的0.3818%。
截至2025年7月16日，公司副總經理崔麗野先生累計減持公司股份42,000股，佔減持前公司股份總數的0.0102%，本次減持計劃已部分實施完畢。本次減持後，其合計持有公司股份數量1,752,692股，佔減持後公司股份總數的0.4213%。
截至2025年7月16日，公司董事蔡文彬先生累計減持公司股份42,000股，佔減持前公司股份總數的0.0102%，本次減持計劃已部分實施完畢。本次減持後，其合計持有公司股份數量1,210,414股，佔減持後公司股份總數的0.2909%。
截至2025年7月16日，公司董事、財務總監沈立華女士累計減持公司股份42,000股，佔減持前公司股份總數的0.0102%，本次減持計劃已部分實施完畢。本次減持後，其合計持有公司股份數量195,840股，佔減持後公司股份總數的0.0471%。
截至2025年7月16日，公司董事陳琳女士累計減持公司股份42,000股，佔減持前公司股份總數的0.0102%，本次減持計劃已實施完畢。本次減持後，其合計持有公司股份數量126,000股，佔減持後公司股份總數的0.0303%。
截至2025年7月16日，公司董事、董事會祕書黃凱先生累計減持公司股份7,200股，佔減持前公司股份總數的0.0017%，本次減持計劃已部分實施完畢。本次減持後，其合計持有公司股份數量261,781股，佔減持後公司股份總數的0.0629%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
